APA (7th ed.) Citation

C, R., O, T., L, D. M., D, D. S., A, S., LE, A., & A, M. (2022). Prevalence and Outcome of Serum Autoantibodies in Chronic Hepatitis C Patients Undergoing Direct-Acting Antiviral Treatment. Frontiers in immunology, 13, 882064. https://doi.org/10.3389/fimmu.2022.882064

Chicago Style (17th ed.) Citation

C, Romano, Tortorella O, Dalla Mora L, Di Stasio D, Sellitto A, Adinolfi LE, and Marrone A. "Prevalence and Outcome of Serum Autoantibodies in Chronic Hepatitis C Patients Undergoing Direct-Acting Antiviral Treatment." Frontiers in Immunology 13 (2022): 882064. https://doi.org/10.3389/fimmu.2022.882064.

MLA (9th ed.) Citation

C, Romano, et al. "Prevalence and Outcome of Serum Autoantibodies in Chronic Hepatitis C Patients Undergoing Direct-Acting Antiviral Treatment." Frontiers in Immunology, vol. 13, 2022, p. 882064, https://doi.org/10.3389/fimmu.2022.882064.